Study: Alsalman 2025, Frontiers in Medicine
Predictors and health impacts of Ramadan intermittent fasting among patients with sickle cell disease
Citation
Alsalman MH, Alsalman Z, Alshams MM, Aljasem JM et al (2025). Frontiers in Medicine. PubMed id 40510850.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Fasting in Ramadan with diabetes or sickle cell Tier B thin
B 320 adult Muslims with sickle cell disease in Saudi Arabia (67% fasted) (n=320)
Cross-sectional interview study.
A history of crises, emergency visits, acute chest syndrome or intensive care admission made fasting the whole month less likely. People with more than four episodes or more than four emergency visits in a year had higher odds of complications in the 30 days after Ramadan. The authors say effects are subtle during the month and larger afterwards.
As recorded in this card: Alsalman MH, Alsalman Z, Alshams MM, Aljasem JM et al (2025), Frontiers in Medicine, [primary]
Note: Self-reported by interview; association only; not a Black population.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.